In contrast to heparin, enoxaparin:
Can be used without monitoring the patient's aPTT
Is less likely to have a teratogenic effect
Is more likely to be given intravenously
Is more likely to cause thrombosis and thrombocytopenia
Enoxaprin is a LMW heparin. It does not require monitoring. Both heparin as well as enoxaprin do not cross placenta and are not teratogenic.
Hematology